SolidWorld Group brings digital biofabrication of living human tissue to the stage at 3DEXPERIENCE World 2025 in Houston

Houston (Texas), February 26, 2025 – SolidWorld Group S.p.A., a company listed on the Euronext Growth Milan market (ticker S3D) and a leader in industrial design, 3D printing, and biofabrication technologies, proudly announces its presence on stage at 3DEXPERIENCE World 2025 by Dassault Systèmes, through its biomedical company Bio3DPrinting.

Aurora De Acutis, President of Bio3DPrinting, spoke at the 3DEXPERIENCE World event in Houston. She presented the development and construction process of the 3D bioprinter capable of biofabricating implantable living material, designed using Dassault Systèmes’ SOLIDWORKS software for the mechanical structure, on which a dedicated software was developed thanks to the synergy between the University of Pisa and SolidWorld Group.

Roberto Rizzo, President of SolidWorld Group, stated:
“Participating in 3DEXPERIENCE World 2025 by Dassault Systèmes is an important recognition of the innovative value that SolidWorld Group and Bio3DPrinting are bringing to the biomedical sector. We are proud to see the Electrospider system, an entirely Italian excellence, showcased on an international stage. Our collaboration with Dassault Systèmes and the integration of our solutions with the 3DEXPERIENCE platform demonstrate how digitalization and 3D printing can revolutionize biomedical research and provide concrete solutions for medicine. This milestone confirms our commitment to making technological innovation a driving force for scientific and healthcare progress.”

Electrospider is an Italian-made breakthrough, developed by Bio3DPrinting, a company holding national and international patents that protect its technology. This innovative biofabrication system leverages additive manufacturing to recreate tissue sections and 3D cellular constructs, forming the foundation of organic structures by utilizing the patient’s own cells. Electrospider’s innovative technology is used in biomedical and oncological applications, providing a cutting-edge solution to support pharmaceutical and cosmetic research, as well as reconstructive surgery. It enables precise fiber deposition and 3D printing of intricate structures through a combined micro-extrusion and electrospinning process, handling multiple materials
simultaneously.

With an extrusion system resembling a spider’s natural form, from which it derives its commercial name, Electrospider releases organic material onto the printing surface, mimicking the workflow of a conventional 3D printer. Layer by layer, the bioprinter reconstructs portions of “living” human tissue, developed from cells cultivated in vitro, extracted directly from the patient undergoing surgery or from donor sources. This process drastically reduces waiting times for implantable materials, lowers rejection risks, and allows for in-depth sample analysis for pharmaceutical, cosmetic, and preoperative research.

Thanks to Dassault Systèmes’ 3DEXPERIENCE platform, advanced data management and seamless collaboration among design, production, and research teams have been made possible. Through a cloud-based infrastructure, every project update was shared in real-time, minimizing errors and reducing revision times.

The adoption of these technologies has made Electrospider a unique and cutting-edge product, featuring high precision, an optimized workflow, and effective collaboration among all development process stakeholders. Finally, thanks to advanced sheet metal modeling capabilities, the structural components of the bioprinter have been designed and optimized, ensuring greater lightness, durability, and ease of assembly.

***

SolidWorld Group S.p.A. is the parent of a group of 13 companies operating in the industrial, biomedical and solar areas founded in the early 2000s by engineer Roberto Rizzo. Listed since July 6, 2022 on the Euronext Growth Milan
segment of Borsa Italiana (ticker S3D), the Group is a leading developer and integrator of the latest and most comprehensive digital 3D software and hardware for manufacturing companies, supporting and accelerating their journey to Industry 5.0. Thanks to SolidWorld, all stages of production – as far as sale and recycling – are integrated using technologies that make the production process faster and more sustainable and efficient. It operates through 16 offices and 3 technology hubs and has over 220 employees and more than 10,000 client enterprises. In 2023, the Group began mass production of Electrospider, a 3D bioprinter capable of reproducing human cell tissues and organs. The acquisition of Valore BF 3d S.r.l. was finalized in 2023, which SolidWorld saw acquire a new client base. In 2023 it completed the transfer of a technology business unit from Formula E S.r.l., a company of the Vismunda S.r.l. Group, a world leader in automation for equipment focusing on the renewable energy sector which enabled SolidWorld Group to enter the solar market. The SolidWorld Group reported revenues of Euro 30.9 million in H1 2024, with a value of production of Euro 40.1 million and EBITDA of Euro 6.3 million. www.solidworldgroup.it

CONTACTS
Investor Relations Manager
Elisabetta Cammarata
investor@solidworld.it

IR & Corporate Media Advisor
TWIN
solidworld@twin.services
Federico Bagatella | T: +39 331 8007258
Mara Di Giorgio | T: +39 335 7737417
Cristina Tronchin | T: +39 348 0782559